SERUM FERRITIN FOR PREDICTING CLINICALLY RELEVANT LIC THRESHOLDS TO GUIDE MANAGEMENT OF PATIENTS WITH NON-TRANSFUSION-DEPENDENT THALASSEMIA TREATED WITH DEFERASIROX: THALASSA STUDY EXTENSION ANALYSIS
Yazar
Viprakasit, V.
Taher, A.
Kattamis, A.
Porter, J.
Habr, D.
Zhu, Z.
Cappellini, M.
Karakas, Zeynep
Galanello, R.
Siritanaratkul, N.
Sutcharitchan, P.
Chuncharunee, S.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Makale [92796]